Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

CuraGen and TopoTarget initiate phase I/II trial of combination therapy for AML

Aug. 29, 2007

Celsion accelerates plans for ThermoDox phase I study in breast cancer

Aug. 29, 2007

Sanofi-aventis launches 200 mg single-use vial of Eloxatin

Aug. 29, 2007

Synthesis and in vivo antitumor activity of EC-0225 described at ACS meeting

Aug. 29, 2007

FDA issues nonapprovable letter for IDM Pharma's mifamurtide NDA

Aug. 29, 2007

ImClone's phase II study of IMC-1121B for renal cancer opens for enrollment

Aug. 28, 2007

Genentech resubmits sBLA to FDA for Avastin combination therapy

Aug. 28, 2007

NCI initiates glycan-based biomarker R&D program for cancer detection

Aug. 28, 2007

BMS continues to search for improved IGF-1R kinase inhibitors

Aug. 27, 2007

Regeneron and sanofi-aventis begin phase III aflibercept oncology program

Aug. 27, 2007

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...